BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Day AS, Leach ST, Lemberg DA. An update on diagnostic and prognostic biomarkers in inflammatory bowel disease. Expert Rev Mol Diagn. 2017;17:835-843. [PMID: 28770636 DOI: 10.1080/14737159.2017.1364160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Koyuncu AG, Akyüz EY. Dietary polyphenols in the treatment of inflammatory bowel diseases. J Surg Med 2022;6:829-832. [DOI: 10.28982/josam.1060925] [Reference Citation Analysis]
2 Volkers AG, Appleton L, Gearry RB, Frampton CM, de Voogd FAE, Peters van Ton AM, Leach ST, Lemberg DA, Day AS. Fecal Calprotectin, Chitinase 3-Like-1, S100A12 and Osteoprotegerin as Markers of Disease Activity in Children with Crohn’s Disease. Gastrointestinal Disorders 2022;4:180-189. [DOI: 10.3390/gidisord4030017] [Reference Citation Analysis]
3 Zhang MH, Wang H, Wang HG, Wen X, Yang XZ. Effective immune-inflammation index for ulcerative colitis and activity assessments. World J Clin Cases 2021; 9(2): 334-343 [PMID: 33521101 DOI: 10.12998/wjcc.v9.i2.334] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
4 Day AS, Lemberg DA. Identification and diagnosis of Crohn disease and ulcerative colitis in children. J Paediatr Child Health 2020;56:1731-4. [PMID: 32468706 DOI: 10.1111/jpc.14925] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Assadsangabi A, Evans CA, Corfe BM, Lobo A. Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives. Gastroenterol Res Pract 2019;2019:1426954. [PMID: 30774653 DOI: 10.1155/2019/1426954] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]